+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson's disease



Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson's disease



Journal of the Neurological Sciences 372: 471-476



Parkinson's disease (PD) patients frequently present visual hallucinations (VHs)·The determinants of VHs in Chinese PD patients remain largely unknown. The aim of this study was to illuminate the prevalence and clinical correlates of VHs in the Chinese population with PD. A total of 371 consecutive, idiopathic PD patients were recruited into the study. Patients were categorized as hallucinators and nonhallucinators according to Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). VHs were observed in 72 (19.4%) patients. Among them, 26.4% of the hallucinators experienced minor hallucinations, and 73.6% had complex visual hallucinations. The age, disease duration, percentage of patients using dopamine agonists, UPDRS part III, Hoehn and Yahr (H-Y) stage, and Non-Motor Symptoms Questionnaire (NMS-Quest) score in hallucinators were significantly greater than in nonhallucinators (P<0.05). The Montreal Cognitive Assessment (MOCA) and PD Sleep Scale (PDSS) scores in nonhallucinators were significantly higher than in hallucinators (P<0.05). The Hamilton Depression Scale (HAMD) and Hamilton Anxiety Scale (HAMA) scores were not different between the hallucinators and nonhallucinators. The forward binary logistic regression model showed that disease duration, dopamine agonist use, sleep quality, and cognition were associated with VHs in PD patients. Our results confirm the high prevalence of VHs in patients with PD. The VHs are associated with duration, dopamine agonist use, sleep quality, and cognition, and should trigger further inquiry by neurologists.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058615123

Download citation: RISBibTeXText

PMID: 27823833

DOI: 10.1016/j.jns.2016.10.043


Related references

Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study. International Journal of Geriatric Psychiatry 28(6): 626-631, 2013

Visual hallucinations and associated factors in Chinese patients with Parkinson's disease: roles of RBD and visual pathway deficit. Parkinsonism and Related Disorders 16(10): 695-696, 2010

Risk factors for visual hallucinations in patients with Parkinson's disease. Neurological Research 37(2): 112-116, 2015

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123: 733-745, 2000

Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease. Bmc Geriatrics 17(1): 270, 2017

A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease. Clinical Neurology and Neurosurgery 130: 98, 2015

Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745. American Journal of Ophthalmology 130(2): 261-262, 2000

Influencing factors of visual hallucinations in patients with Parkinson's disease and its relationship with sleep disorders. Zhonghua Yi Xue Za Zhi 96(13): 1016-1020, 2016

Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment. Human Brain Mapping 37(3): 968-977, 2016

Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology 19(1): 36-40, 2006

Factors associated with drug-induced visual hallucinations in Parkinson's disease. Journal of Neurology 252(10): 1223-1228, 2005

Visual object recognition and attention in Parkinson's disease patients with visual hallucinations. Movement Disorders 23(13): 1906-1912, 2008

The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot study. Clinical Neuropharmacology 32(5): 266-268, 2010

Preliminary FMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations. Journal of Neuropsychiatry and Clinical Neurosciences 18(3): 402-404, 2006

Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 132(Pt 11): 2980-2993, 2009